Skip to main content

Table 1 Comparison of subjects carrying BRCA mutations

From: Changes in body weight and the risk of breast cancer in BRCA1 and BRCA2mutation carriers

Variable

Control subjects (n = 1,073)

Case subjects (n = 1,073)

P a

Age (years) at interview, no. (%)

   

   ≤ 30

17 (1.6)

26 (2.4)

 

   31–40

219 (20.4)

242 (22.5)

 

   41–50

415 (38.7)

386 (36.0)

 

   51–60

277 (25.8)

264 (24.6)

 

   ≥ 61

145 (13.5)

155 (14.5)

0.32

Age (years) at interview, mean (SD)

47.9 (10.6)

48.6 (10.6)

0.25

Date of birth, mean year

1951.8

1951.2

0.14

Year of interview, mean (range)

1999.7 (1995–2004)

1999.8 (1999–2004)

0.18

Age (years) at diagnosis of breast cancer, no. (%)

   

   ≤ 30

NA

107 (10.0)

 

   31–40

 

478 (44.5)

 

   41–50

 

371 (34.5)

 

   ≥ 51

 

117 (10.9)

 

Age (years) at diagnosis of breast cancer, mean (SD)

 

39.8 (8.3)

 

Mutation, %

   

   BRCA1

74.3

74.3

 

   BRCA2

25.7

25.7

 

Parity

   

   No. (%) parous

844 (79.6)

879 (82.8)

0.06

   Parity, mean (SD)

1.9 (1.4)

1.9 (1.3)

0.18

No. (%) who ever used oral contraceptives

662 (62.6)

710 (66.8)

0.04

No. (%) who ever smoked

465 (43.3)

471 (43.9)

0.79

   Country of residence at time of testing, no. (%)

   

   Canada

420 (39.1)

420 (39.1)

 

   Israel

20 (1.9)

20 (1.9)

 

   UK

8 (0.8)

8 (0.8)

 

   Poland

189 (17.6)

189 (17.6)

 

   USA

436 (40.6)

436 (40.6)

 
  1. aAll P values are univariate and were derived using Student's t-test for continuous variables and the χ2 test for categorical variables. NA, not applicable; SD, standard deviation.